NasdaqGS - Nasdaq Real Time Price ? USD InMode Ltd. (INMD) Follow Compare 17.27 +0.19 (+1.11%) As of 1:20 PM EDT. Market Open. All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations InMode Third Quarter 2024 Earnings: Beats Expectations InMode ( NASDAQ:INMD ) Third Quarter 2024 Results Key Financial Results Revenue: US$130.2m (up 5.8% from 3Q 2023). Net... Simply Wall St. ? 4 hours ago INMD +1.11% InMode Sees Revenue Growth Amidst Challenges in Q3 2024 InMode (INMD) has released an update. InMode Ltd. posted a 5.8% increase in third-quarter 2024 revenues, reaching $130.2 million, although the company adjusted its full-year revenue guidance down to between $410 million and $420 million. Despite challenges such as decreased demand for consumables and operational hiccups due to macroeconomic conditions and recent management changes, InMode maintains a strong cash position of $684.9 million. The company’s net income rose to $51.0 million, or $0.65 TipRanks ? yesterday INMD +1.11% InMode Ltd (INMD) Q3 2024 Earnings Call Highlights: Navigating Challenges with Strategic Adjustments Despite macroeconomic headwinds and international sales decline, InMode Ltd (INMD) maintains strong earnings and revises guidance for 2024. GuruFocus.com ? yesterday INMD +1.11% Q3 2024 Inmode Ltd Earnings Call Q3 2024 Inmode Ltd Earnings Call Thomson Reuters StreetEvents ? yesterday INMD +1.11% InMode (INMD) Q3 2024 Earnings Call Transcript INMD earnings call for the period ending September 30, 2024. Motley Fool ? yesterday INMD +1.11% InMode (INMD) Q3 Earnings and Revenues Beat Estimates InMode (INMD) delivered earnings and revenue surprises of 22.81% and 0.18%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock? Zacks ? 2 days ago INMD +1.11% InMode: Q3 Earnings Snapshot YOKNEAM, Israel (AP) — InMode Ltd. (INMD) on Wednesday reported net income of $51 million in its third quarter. The Yokneam, Israel-based company said it had profit of 65 cents per share. Earnings, adjusted for stock option expense, were 70 cents per share. Associated Press Finance ? 2 days ago INMD +1.11% InMode Reports Third Quarter 2024 Financial Results; Quarterly GAAP Revenue of $130.2 Million (which consists of $98.3 million of net sales in Q3 and $31.9 million of pre-orders from the first half of 2024) InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced its consolidated financial results for the third quarter ended September 30, 2024. PR Newswire ? 2 days ago INMD +1.11% InMode Granted Preliminary Injunction Against Online Sellers Prohibiting Counterfeit Sales of Morpheus8 Radiofrequency Devices and Cartridge Accessories InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, has been granted a preliminary injunction by the U.S. District Court for the Central District of California in a lawsuit filed against sellers identified to be the source of unlawful counterfeit sales of Morpheus8 radiofrequency devices and cartridge accessories. PR Newswire ? 8 days ago INMD +1.11% Earnings Preview: InMode (INMD) Q3 Earnings Expected to Decline InMode (INMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. Zacks ? 9 days ago INMD +1.11% Is InMode (INMD) a Great Value Stock Right Now? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. Zacks ? 18 days ago INMD +1.11% InMode price target lowered to $27 from $29 at Barclays Barclays analyst Matt Miksic lowered the firm’s price target on InMode to $27 from $29 and keeps an Overweight rating on the shares. The company’s preliminary Q3 sales were above consensus on a pro forma basis, “importantly clearing back-orders of new products,” the analyst tells investors in a research note. However, the firm says management viewed the Q3 results as in line with internal objectives and in line with typical Q3 seasonality. It is encouraged by the initial Q3 results. Published fi TipRanks ? 18 days ago INMD +1.11% InMode to Report Third Quarter 2024 Financial Results and Hold Conference Call on October 30, 2024 InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its financial results for the third quarter of 2024 before the Nasdaq market opens on Wednesday, October 30, 2024. PR Newswire ? 22 days ago INMD +1.11% InMode Ltd (INMD) Q2 2024 Earnings Call Highlights: Navigating Challenges with New Innovations Despite a challenging quarter, InMode Ltd (INMD) remains optimistic with new platform launches and strategic investments. GuruFocus.com ? 22 days ago INMD +1.11% InMode Restructures Amidst Global Expansion InMode (INMD) has released an update. InMode Ltd., a leading innovator in medical technology, is undergoing a significant reorganization which has led to the departure of key North American executives, including the President of North America, the Chief Medical Officer, and the VP of Sales USA. The company is restructuring to better align with its global expansion and entry into new markets, particularly the wellness sector. As part of this strategy, InMode is set to introduce a suite of new pla TipRanks ? 30 days ago INMD +1.11% InMode Ltd.'s (NASDAQ:INMD) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason? InMode's (NASDAQ:INMD) stock is up by 3.3% over the past week. Given that the market rewards strong financials in the... Simply Wall St. ? last month INMD +1.11% InMode Announces Departures of President of North America, Chief Medical Officer and VP of Sales USA as Part of a Global Reorganization Strategy InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies today announced the departure of Shakil Lakhani, President of North America effective September 30, 2024. His departure follows that of Dr. Spero Theodorou, Chief Medical Officer, and Dan Wilson, VP of Sales USA. PR Newswire ? last month INMD +1.11% Should Value Investors Buy InMode (INMD) Stock? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. Zacks ? last month INMD +1.11% InMode (INMD): Among the Worst Middle East and Africa Stocks to Buy Now We recently compiled a list of the 10 Worst Middle East and Africa Stocks To Buy According to Short Sellers. In this article, we are going to take a look at where InMode (NASDAQ:INMD) stands against the other Middle East and Africa stocks. Moderate Growth Amidst Challenges According to the IMF’s Middle East and North Africa […] Insider Monkey ? last month INMD +1.11% Are Investors Undervaluing InMode (INMD) Right Now? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. Zacks ? last month INMD +1.11% Performance Overview Trailing total returns as of 11/1/2024, which may include dividends or other distributions. Benchmark is S&P 500 Return INMD S&P 500 YTD -22.35% +20.56% 1-Year -9.58% +37.12% 3-Year -81.77% +24.87%
